Rachel Bittner

1.4k total citations
14 papers, 1.1k citations indexed

About

Rachel Bittner is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Rachel Bittner has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Rachel Bittner's work include CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Influenza Virus Research Studies (2 papers). Rachel Bittner is often cited by papers focused on CAR-T cell therapy research (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Influenza Virus Research Studies (2 papers). Rachel Bittner collaborates with scholars based in United States, Canada and Germany. Rachel Bittner's co-authors include Margaret Rosenfeld, Don B. Sanders, Christopher H. Goss, Gregory J. Redding, Lucas R. Hoffman, Lisa A. Jackson, Onchee Yu, Patrick J. Healey, Michael L. Jackson and Jennifer C. Nelson and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and American Journal of Public Health.

In The Last Decade

Rachel Bittner

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Bittner United States 12 612 428 106 81 78 14 1.1k
Andrea Gramegna Italy 20 701 1.1× 256 0.6× 77 0.7× 43 0.5× 157 2.0× 82 1.1k
Casper S. de Graaff Netherlands 15 732 1.2× 546 1.3× 72 0.7× 32 0.4× 64 0.8× 27 1.2k
J. Angrill Spain 16 986 1.6× 534 1.2× 98 0.9× 26 0.3× 74 0.9× 24 1.4k
Francesco Amati Italy 15 424 0.7× 248 0.6× 55 0.5× 41 0.5× 125 1.6× 52 809
Fernando M. de Benedictis Italy 19 387 0.6× 396 0.9× 220 2.1× 26 0.3× 52 0.7× 48 1.2k
Jenene Noll United States 11 259 0.4× 243 0.6× 122 1.2× 84 1.0× 65 0.8× 13 786
Noel Karalus New Zealand 16 823 1.3× 636 1.5× 73 0.7× 14 0.2× 58 0.7× 31 1.5k
Luis Borderías Spain 23 579 0.9× 817 1.9× 65 0.6× 19 0.2× 50 0.6× 72 1.5k
Anne E. O’Donnell United States 19 1.5k 2.5× 603 1.4× 131 1.2× 46 0.6× 78 1.0× 51 2.0k
Leonardo Terranova Italy 20 319 0.5× 423 1.0× 41 0.4× 32 0.4× 113 1.4× 51 980

Countries citing papers authored by Rachel Bittner

Since Specialization
Citations

This map shows the geographic impact of Rachel Bittner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Bittner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Bittner more than expected).

Fields of papers citing papers by Rachel Bittner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Bittner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Bittner. The network helps show where Rachel Bittner may publish in the future.

Co-authorship network of co-authors of Rachel Bittner

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Bittner. A scholar is included among the top collaborators of Rachel Bittner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Bittner. Rachel Bittner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Bhatia, Shailender, Brendan D. Curti, Marc S. Ernstoff, et al.. (2014). Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 study. Journal for ImmunoTherapy of Cancer. 2(1). 2–2. 46 indexed citations
2.
Chow, Laura Q.M., Michael S. Gordon, Theodore F. Logan, et al.. (2013). Phase I dose escalation study of recombinant interleukin-21 (rIL-21; BMS-982470) in combination with nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with advanced or metastatic solid tumors.. Journal of Clinical Oncology. 31(15_suppl). TPS3112–TPS3112. 7 indexed citations
3.
Chabra, Shilpi, et al.. (2013). Vitamin A Status After Prophylactic Intramuscular Vitamin A Supplementation in Extremely Low Birth Weight Infants. Nutrition in Clinical Practice. 28(3). 381–386. 15 indexed citations
4.
Bhatia, Shailender, Brendan D. Curti, Michael S. Gordon, et al.. (2013). Phase I dose escalation study of recombinant interleukin-21 (rIL-21, BMS-982470) in combination with ipilimumab (Ipi) in patients (pts) with advanced or metastatic melanoma (MM).. Journal of Clinical Oncology. 31(15_suppl). TPS3109–TPS3109. 2 indexed citations
5.
Brown, Julie C., et al.. (2012). The Utility of Adding Expiratory or Decubitus Chest Radiographs to the Radiographic Evaluation of Suspected Pediatric Airway Foreign Bodies. Annals of Emergency Medicine. 61(1). 19–26. 21 indexed citations
6.
Wiater, Brett P., J. Lee Pace, Thomas M. Jinguji, et al.. (2011). The Lateral Capitellohumeral Angle in Normal Children. Journal of Pediatric Orthopaedics. 31(3). 266–271. 47 indexed citations
7.
Shnorhavorian, Margarett, Rachel Bittner, Jonathan L. Wright, & Stephen M. Schwartz. (2011). Maternal Risk Factors for Congenital Urinary Anomalies: Results of a Population-based Case-control Study. Urology. 78(5). 1156–1161. 35 indexed citations
8.
Javid, Patrick J., Frances R. Malone, Rachel Bittner, Patrick J. Healey, & Simon Horslen. (2011). The optimal timing of referral to an intestinal failure program: the relationship between hyperbilirubinemia and mortality. Journal of Pediatric Surgery. 46(6). 1052–1056. 15 indexed citations
9.
Sanders, Don B., Rachel Bittner, Margaret Rosenfeld, et al.. (2010). Failure to Recover to Baseline Pulmonary Function after Cystic Fibrosis Pulmonary Exacerbation. American Journal of Respiratory and Critical Care Medicine. 182(5). 627–632. 399 indexed citations
10.
Smith, Jodi M., Lawrence Corey, Rachel Bittner, et al.. (2010). Subclinical Viremia Increases Risk for Chronic Allograft Injury in Pediatric Renal Transplantation. Journal of the American Society of Nephrology. 21(9). 1579–1586. 82 indexed citations
11.
Sanders, Don B., Rachel Bittner, Margaret Rosenfeld, Gregory J. Redding, & Christopher H. Goss. (2010). Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis. Pediatric Pulmonology. 46(4). 393–400. 201 indexed citations
12.
13.
Nelson, Jennifer C., Rachel Bittner, Shanshan Zhao, et al.. (2009). Compliance With Multiple-Dose Vaccine Schedules Among Older Children, Adolescents, and Adults: Results From a Vaccine Safety Datalink Study. American Journal of Public Health. 99(S2). S389–S397. 89 indexed citations
14.
Nelson, Jennifer C., Michael L. Jackson, Onchee Yu, et al.. (2008). Impact of the introduction of pneumococcal conjugate vaccine on rates of community acquired pneumonia in children and adults. Vaccine. 26(38). 4947–4954. 122 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Gramegna Breakdown of academic impact, for papers by Casper S. de Graaff Breakdown of academic impact, for papers by J. Angrill Breakdown of academic impact, for papers by Francesco Amati Breakdown of academic impact, for papers by Fernando M. de Benedictis Breakdown of academic impact, for papers by Jenene Noll Breakdown of academic impact, for papers by Noel Karalus Breakdown of academic impact, for papers by Luis Borderías Breakdown of academic impact, for papers by Anne E. O’Donnell Breakdown of academic impact, for papers by Leonardo Terranova
Rankless by CCL
2026